Patents by Inventor John J. Baldwin

John J. Baldwin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2-Substituted propoxy-3-cyano-5-hydroxypyridines and use as antihypertensives
    Patent number: 4374140
    Abstract: The present application discloses certain 2-substituted propoxy-3-cyano-5-hydroxypyridines. The compounds have pharmaceutical activity e.g. as antihypertensives.
    Type: Grant
    Filed: February 10, 1981
    Date of Patent: February 15, 1983
    Assignee: Merck & Co., Inc.
    Inventors: John J. Baldwin, Gerald S. Ponticello, Stanley Vickers, Alfred Steuerwald
  • Aralkylamindethanol heterocyclic compounds
    Patent number: 4358455
    Abstract: Heterocyclic aminoethanols of the formulaHet--CHOH--CH.sub.2 --NH--aralkylwhere het is a 6-10 membered N heterocycle are disclosed. The compounds are useful as pharmaceuticals.
    Type: Grant
    Filed: December 23, 1980
    Date of Patent: November 9, 1982
    Assignee: Merck & Co., Inc.
    Inventors: Joseph G. Atkinson, John J. Baldwin, David E. McClure
  • Benzoxazines
    Patent number: 4349673
    Abstract: Compounds of the formula Het--O--CH.sub.2 --CHOR--CH.sub.2 -NHaralkyl where Het is a 10 membered N-containing ring are disclosed. The compounds are useful as pharmaceuticals.
    Type: Grant
    Filed: December 23, 1980
    Date of Patent: September 14, 1982
    Assignees: Merck & Co., Inc., Merck Sharp & Dohme Corp.
    Inventors: Joseph G. Atkinson, John J. Baldwin, David E. McClure
  • Preparation of epihalohydrin enantiomers
    Patent number: 4346042
    Abstract: Processes for preparing (S) or (R) epihalohydrin and an (S) substituted glycerol intermediate are disclosed.
    Type: Grant
    Filed: May 5, 1980
    Date of Patent: August 24, 1982
    Assignee: Merck & Co., Inc.
    Inventors: John J. Baldwin, David E. McClure
  • Aryloxypropanolamines
    Patent number: 4336261
    Abstract: Aryloxypropanolamines, their preparation and use as pharmaceuticals is disclosed.
    Type: Grant
    Filed: December 15, 1980
    Date of Patent: June 22, 1982
    Assignee: Merck & Co., Inc.
    Inventors: John J. Baldwin, David E. McClure
  • Novel 2-pyridylbenzimidazole compounds
    Patent number: 4336257
    Abstract: Novel alkylsubstituted 2-pyridylimidazoles, halosubstituted-2-pyridylbenzimidazoles, and 2-pyridylimidazopyridines are disclosed. The compounds have pharmaceutical utility as xanthine oxidase inhibitors and/or as antihypertensives.
    Type: Grant
    Filed: August 8, 1980
    Date of Patent: June 22, 1982
    Assignee: Merck & Co., Inc.
    Inventor: John J. Baldwin
  • Imidazoazines and imidazodiazines
    Patent number: 4330543
    Abstract: Novel imidazopyridines, -pyrazines, -pyrimidines and -pyridazines having a 3-amino-2-OR-propoxy substituent, are disclosed. The compounds have .beta.-adrenergic blocking activity.
    Type: Grant
    Filed: March 28, 1980
    Date of Patent: May 18, 1982
    Assignee: Merck & Co., Inc.
    Inventors: John J. Baldwin, William C. Lumma, Jr.
  • 2-Substituted propoxy-3-cyano-5-RO-pyridines and intermediates
    Patent number: 4329351
    Abstract: The present application discloses 2-substituted propoxy-3-cyano-5-RO-pyridines and intermediates therefor. The former compounds have pharmaceutical activity.
    Type: Grant
    Filed: October 1, 1979
    Date of Patent: May 11, 1982
    Assignee: Merck & Co., Inc.
    Inventors: John J. Baldwin, Gerald S. Ponticello
  • Process for producing 2-bromo-3,5-disubstituted pyridines
    Patent number: 4294969
    Abstract: Novel substituted (3-loweralkylamino-2-R.sub.1 O-propoxy)pyridines, their pharmaceutically acceptable salts, certain intermediates and their preparation are disclosed. These pyridines have pharmaceutically useful properties such as .beta.-adrenergic blocking activity.
    Type: Grant
    Filed: July 11, 1980
    Date of Patent: October 13, 1981
    Assignee: Merck & Co., Inc.
    Inventors: John J. Baldwin, Gerald S. Ponticello
  • Amino substituted tetrahydrobenzindoles
    Patent number: 4282240
    Abstract: Aminosubstituted tetrahydrobenzindoles having antihypertensive activity are disclosed.
    Type: Grant
    Filed: November 23, 1979
    Date of Patent: August 4, 1981
    Assignee: Merck & Co., Inc.
    Inventors: John J. Baldwin, James H. Jones, George F. Lundell
  • Novel 2-pyridylimidazole compounds
    Patent number: 4281005
    Abstract: Novel alkylsubstituted 2-pyridylimidazoles, halosubstituted-2-pyridylbenzimidazoles, and 2-pyridylimidazopyridines are disclosed. The compounds have pharmaceutical utility as xanthine oxidase inhibitors and/or as antihypertensive.
    Type: Grant
    Filed: June 6, 1980
    Date of Patent: July 28, 1981
    Assignee: Merck & Co., Inc.
    Inventor: John J. Baldwin
  • Polysubstituted-2-(3-loweralkylamino-2-R.sub.1 O-propoxy)pyridines
    Patent number: 4279913
    Abstract: Novel substituted (3-loweralkylamino-2-R.sub.1 O-propoxy)pyridines, their pharmaceutically acceptable salts, certain intermediates and their preparation are disclosed. These pyridines have pharmaceutically useful properties such as .beta.-adrenergic blocking activity.
    Type: Grant
    Filed: January 29, 1979
    Date of Patent: July 21, 1981
    Assignee: Merck & Co., Inc.
    Inventors: John J. Baldwin, Gerald S. Ponticello
  • N-Aralkyl containing cyanopyridines
    Patent number: 4263307
    Abstract: N-Aralkylamino-OR-propoxycyanopyridines having pharmacological activity are disclosed.
    Type: Grant
    Filed: August 2, 1979
    Date of Patent: April 21, 1981
    Assignee: Merck & Co., Inc.
    Inventor: John J. Baldwin
  • Di- and tri- substituted thiazoles
    Patent number: 4260609
    Abstract: Di- and tri- substituted thiazoles, one substituent being a 3-amino-2-OR-propoxy group are disclosed. The thiazoles have .beta.-adrenergic blocking activity.
    Type: Grant
    Filed: April 17, 1978
    Date of Patent: April 7, 1981
    Assignee: Merck & Co., Inc.
    Inventors: John J. Baldwin, Gerald S. Ponticello
  • Substituted aminoalkoxypyridines, compositions and use thereof
    Patent number: 4259327
    Abstract: Substituted aminoalkoxypyridines are disclosed. The compounds are useful as pharmaceutical agents.
    Type: Grant
    Filed: April 2, 1979
    Date of Patent: March 31, 1981
    Assignee: Merck & Co., Inc.
    Inventor: John J. Baldwin
  • Di- and tri-substituted thiazoles
    Patent number: 4259341
    Abstract: Di- and tri-substituted thiazoles, one substituent being a 3-amino-2-OR-propoxy group are disclosed. The thiazoles have .beta.-adrenergic blocking activity.
    Type: Grant
    Filed: November 13, 1978
    Date of Patent: March 31, 1981
    Assignee: Merck & Co., Inc.
    Inventors: John J. Baldwin, Gerald S. Ponticello
  • 1,2,4-Triazoles and a method for their preparation
    Patent number: 4256887
    Abstract: Triazoles substituted at the 3 and 5 positions having an optional substituent in the 1 position are provided. Methods of preparing the novel substituted triazoles are described. The substituted triazoles are useful as anti-gout and anti-hyperuricomic agents. Compositions useful in the treatment of gout and hyperuricomia containing a substituted triazole as the active ingredient are also provided.
    Type: Grant
    Filed: September 13, 1979
    Date of Patent: March 17, 1981
    Assignee: Merck & Co., Inc.
    Inventors: Frederick C. Novello, John J. Baldwin
  • Thiosubstituted pyridines
    Patent number: 4251663
    Abstract: 3-Trifluorothiomethyl-2-(3-loweralkylamino-2-R.sub.1 O-propoxy)pyridines, their pharmaceutically acceptable salts certain intermediates and their preparation are disclosed. These pyridines have pharmaceutical properties such as antihypertensive activity of rapid onset.
    Type: Grant
    Filed: February 4, 1980
    Date of Patent: February 17, 1981
    Assignee: Merck & Co., Inc.
    Inventors: John J. Baldwin, Gerald S. Ponticello
  • Thiosubstituted pyridines
    Patent number: 4234590
    Abstract: 3-Trifluoromethylthio-2-(3-loweralkylamino-2-R.sub.1 O-propoxy)pyridines, their pharmaceutically acceptable salts certain intermediates and their preparation are disclosed. These pyridines have pharmaceutical properties such as antihypertensive activity of rapid onset.
    Type: Grant
    Filed: February 5, 1979
    Date of Patent: November 18, 1980
    Assignee: Merck & Co., Inc.
    Inventors: John J. Baldwin, Gerald S. Ponticello
  • Novel imidazoazines and imidazodiazines
    Patent number: 4233301
    Abstract: Novel imidazopyridines, -pyrazines, -pyrimidines and -pyridazines having a 3-amino-2-OR-propoxy substituent, are disclosed. The compounds have .beta.-adrenergic blocking activity.
    Type: Grant
    Filed: December 14, 1978
    Date of Patent: November 11, 1980
    Assignee: Merck & Co., Inc.
    Inventors: John J. Baldwin, William C. Lumma, Jr.